Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Staphylococcus aureus in early cystic fibrosis lung disease.

Wong JK, Ranganathan SC, Hart E; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF).

Pediatr Pulmonol. 2013 Dec;48(12):1151-9. doi: 10.1002/ppul.22863. Epub 2013 Aug 22. Review.

PMID:
23970476
[PubMed - indexed for MEDLINE]
2.

Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis.

Wolter DJ, Emerson JC, McNamara S, Buccat AM, Qin X, Cochrane E, Houston LS, Rogers GB, Marsh P, Prehar K, Pope CE, Blackledge M, Déziel E, Bruce KD, Ramsey BW, Gibson RL, Burns JL, Hoffman LR.

Clin Infect Dis. 2013 Aug;57(3):384-91. doi: 10.1093/cid/cit270. Epub 2013 Apr 26.

PMID:
23625938
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis.

Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM Jr, Buller RS, Armstrong JR, Mardis ER, Storch GA, Cannon CL.

Chest. 2007 Jun;131(6):1718-25. Epub 2007 Mar 30.

PMID:
17400676
[PubMed - indexed for MEDLINE]
4.

Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.

Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, Regelmann WE; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2007 Jun;42(6):513-8.

PMID:
17469151
[PubMed - indexed for MEDLINE]
5.

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.

Smyth AR, Walters S.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001912. doi: 10.1002/14651858.CD001912.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD001912.

PMID:
23235585
[PubMed - indexed for MEDLINE]
6.

Pulmonary infection in mild variant cystic fibrosis: implications for care.

Lording A, McGaw J, Dalton A, Beal G, Everard M, Taylor CJ.

J Cyst Fibros. 2006 May;5(2):101-4. Epub 2006 Jan 19.

PMID:
16426904
[PubMed - indexed for MEDLINE]
Free Article
7.

Changes in strategies for optimal antibacterial therapy in cystic fibrosis.

Ratjen F.

Int J Antimicrob Agents. 2001 Feb;17(2):93-6. Review.

PMID:
11165111
[PubMed - indexed for MEDLINE]
8.

[Treatment of staphylococcal infection in cystic fibrosis].

Sermet-Gaudelus I.

Rev Mal Respir. 2003 Apr;20(2 Pt 2):S91-9. Review. French. No abstract available.

PMID:
12910140
[PubMed - indexed for MEDLINE]
9.

Update on antibiotics for infection control in cystic fibrosis.

Kirkby S, Novak K, McCoy K.

Expert Rev Anti Infect Ther. 2009 Oct;7(8):967-80. doi: 10.1586/eri.09.82. Review.

PMID:
19803706
[PubMed - indexed for MEDLINE]
10.

Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation.

Hirschhausen N, Block D, Bianconi I, Bragonzi A, Birtel J, Lee JC, Dübbers A, Küster P, Kahl J, Peters G, Kahl BC.

Int J Med Microbiol. 2013 Dec;303(8):685-92. doi: 10.1016/j.ijmm.2013.09.012. Epub 2013 Oct 8.

PMID:
24183484
[PubMed - indexed for MEDLINE]
11.

Prophylactic antibiotics for cystic fibrosis.

Smyth A, Walters S.

Cochrane Database Syst Rev. 2003;(3):CD001912. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001912.

PMID:
12917916
[PubMed - indexed for MEDLINE]
12.

Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Lo DK, Hurley MN, Muhlebach MS, Smyth AR.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD009650. doi: 10.1002/14651858.CD009650.pub2. Review.

PMID:
23450608
[PubMed - indexed for MEDLINE]
13.

Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence.

Ulrich M, Herbert S, Berger J, Bellon G, Louis D, Münker G, Döring G.

Am J Respir Cell Mol Biol. 1998 Jul;19(1):83-91.

PMID:
9651183
[PubMed - indexed for MEDLINE]
14.
15.

Adaptation of Staphylococcus aureus to the cystic fibrosis lung.

Goerke C, Wolz C.

Int J Med Microbiol. 2010 Dec;300(8):520-5. doi: 10.1016/j.ijmm.2010.08.003. Epub 2010 Sep 16. Review.

PMID:
20843740
[PubMed - indexed for MEDLINE]
16.

Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?

Smyth A.

Pediatr Pulmonol. 2005 Dec;40(6):471-6. Review.

PMID:
16200640
[PubMed - indexed for MEDLINE]
17.

Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW; Inhaled Tobramycin in Young Children Study Group; Cystic Fibrosis Foundation Therapeutics Development Network.

J Pediatr. 2009 Feb;154(2):183-8. doi: 10.1016/j.jpeds.2008.08.001. Epub 2008 Sep 25.

PMID:
18822427
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Clinical experiences with fusidic acid in cystic fibrosis patients.

Jensen T, Lanng S, Faber M, Rosdahl VT, Høiby N, Koch C.

J Antimicrob Chemother. 1990 Feb;25 Suppl B:45-52.

PMID:
2312445
[PubMed - indexed for MEDLINE]
19.

[Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].

Coman G, Petraru E, Dahorea C, Anton DT.

Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):580-7. Romanian.

PMID:
23077957
[PubMed - indexed for MEDLINE]
20.

Review: Staphylococcus aureus and MRSA in cystic fibrosis.

Goss CH, Muhlebach MS.

J Cyst Fibros. 2011 Sep;10(5):298-306. doi: 10.1016/j.jcf.2011.06.002. Epub 2011 Jun 29. Review.

PMID:
21719362
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk